OPPM
Opus Point Partners Management Portfolio holdings
AUM
$46.9M
This Quarter Return
+19.96%
1 Year Return
-4.17%
3 Year Return
+83.22%
5 Year Return
+175.29%
10 Year Return
–
AUM
$99M
AUM Growth
–
Cap. Flow
+$99M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
38.62%
Holding
52
New
50
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
ProShares Ultra NASDAQ Biotechnology
BIB
|
$4.79M |
| 2 |
Incyte
INCY
|
$4.45M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$3.95M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$3.88M |
| 5 |
CELG
Celgene Corp
CELG
|
$3.7M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 71.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
ProShares Ultra NASDAQ Biotechnology
BIB
$53.6M
| $4.79M | 4.74% | +38,184 | New | +$4.79M |
|
|
2
Incyte
INCY
$16.5B
| $4.45M | 4.4% | +60,877 | New | +$4.45M |
|
|
3
BioMarin Pharmaceuticals
BMRN
$11.2B
| $3.95M | 3.91% | +43,731 | New | +$3.95M |
|
|
4
SPDR S&P Biotech ETF
XBI
$5.07B
| $3.88M | 3.84% | +20,800 | New | +$3.88M |
|
|
CELG
5
DELISTED
Celgene Corp
CELG
| $3.7M | 3.66% | +33,040 | New | +$3.7M |
|
6
Nektar Therapeutics
NKTR
$568M
| $3.68M | 3.64% | +237,109 | New | +$3.68M |
|
7
Regeneron Pharmaceuticals
REGN
$61.5B
| $3.55M | 3.51% | +8,650 | New | +$3.55M |
|
8
Vertex Pharmaceuticals
VRTX
$100B
| $3.46M | 3.42% | +29,096 | New | +$3.46M |
|
9
Illumina
ILMN
$15.8B
| $3.4M | 3.36% | +18,394 | New | +$3.4M |
|
|
ALXN
10
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $3.39M | 3.36% | +18,332 | New | +$3.39M |
|
|
CPHD
11
DELISTED
Cepheid Inc
CPHD
| $3.27M | 3.23% | +60,386 | New | +$3.27M |
|
12
Biogen
BIIB
$19.4B
| $3.22M | 3.19% | +9,486 | New | +$3.22M |
|
|
PCYC
13
DELISTED
PHARMACYCLICS INC
PCYC
| $3.15M | 3.11% | +25,723 | New | +$3.15M |
|
|
MDVN
14
DELISTED
MEDIVATION, INC.
MDVN
| $3.13M | 3.09% | +31,377 | New | +$3.13M |
|
15
Mettler-Toledo International
MTD
$26.8B
| $3.03M | 2.99% | +10,000 | New | +$3.03M |
|
|
RCPT
16
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $2.81M | 2.78% | +22,971 | New | +$2.81M |
|
17
Ionis Pharmaceuticals
IONS
$6.79B
| $2.8M | 2.77% | +45,418 | New | +$2.8M |
|
18
Amgen
AMGN
$155B
| $2.72M | 2.69% | +17,046 | New | +$2.72M |
|
|
QGENF
19
DELISTED
QIAGEN NV
QGENF
| $2.67M | 2.65% | +114,000 | New | +$2.67M |
|
|
SGEN
20
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.64M | 2.61% | +82,253 | New | +$2.64M |
|
21
Bio-Techne
TECH
$8.5B
| $2.58M | 2.55% | +27,900 | New | +$2.58M |
|
22
United Therapeutics
UTHR
$13.8B
| $2.47M | 2.44% | +19,054 | New | +$2.47M |
|
|
SLXP
23
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $2.09M | 2.07% | +18,187 | New | +$2.09M |
|
|
GEVA
24
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $1.86M | 1.84% | +20,002 | New | +$1.86M |
|
25
Alnylam Pharmaceuticals
ALNY
$58.5B
| $1.73M | 1.72% | +17,875 | New | +$1.73M |
|